Swiss - Delayed Quote CHF

Kuros Biosciences AG (KURN.SW)

20.64 -0.20 (-0.96%)

At close: October 30 at 5:30:30 PM GMT+1

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Kuros Biosciences (SWX:KURN) Lifts Guidance On A Valuation That Still Looks Pricey

Simply Wall St. 5d ago

KURN.SW
-0.96%
KURN
Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

GlobeNewswire 16d ago

KURN.SW
-0.96%
Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

GlobeNewswire 2mo ago

KURN.SW
-0.96%
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich

GlobeNewswire 4mo ago

KURN.SW
-0.96%
European Growth Stocks With High Insider Ownership

Simply Wall St. 4mo ago

KURN.SW
-0.96%
CDR.WA

VGO.WA
European Growth Stocks With Strong Insider Ownership

Simply Wall St. 4mo ago

KURN.SW
-0.96%
CDR.WA

LEON.SW
European Growth Companies With Strong Insider Ownership June 2026

Simply Wall St. 4mo ago

KURN.SW
-0.96%
CDR.WA

VGO.WA
European Growth Companies With High Insider Ownership For June 2026

Simply Wall St. 4mo ago

KURN.SW
-0.96%
CDR.WA

VGO.WA
Annual General Meeting of Kuros Biosciences approves all resolutions

GlobeNewswire 6mo ago

KURN.SW
-0.96%
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

GlobeNewswire 6mo ago

KURN.SW
-0.96%
European Growth Companies With High Insider Ownership June 2026

Simply Wall St. 4mo ago

BCS.OL

KURN.SW
-0.96%
CDR.WA
Top European Growth Companies With High Insider Ownership June 2026

Simply Wall St. 4mo ago

^GDAXI

KURN.SW
-0.96%
CDR.WA

Performance Overview

Return	KURN.SW	MSCI WORLD (^990100-USD-STRD)
YTD	-24.89%	+9.06%
1-Year	-29.65%	+9.89%
3-Year	+703.11%	--

U.S. markets closed

Kuros Biosciences AG (KURN.SW)

Kuros Biosciences (SWX:KURN) Lifts Guidance On A Valuation That Still Looks Pricey

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Kuros Biosciences delivers 45% H1 2026 year-over-year sales growth and increases overall profitability

Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich

European Growth Stocks With High Insider Ownership

European Growth Stocks With Strong Insider Ownership

European Growth Companies With Strong Insider Ownership June 2026

European Growth Companies With High Insider Ownership For June 2026

Annual General Meeting of Kuros Biosciences approves all resolutions

Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026

European Growth Companies With High Insider Ownership June 2026

Top European Growth Companies With High Insider Ownership June 2026